Schedule I - Condensed Financial Information of Parent (Tables)
|
12 Months Ended |
Dec. 31, 2021 |
|---|
| Condensed Financial Information Disclosure [Abstract] |
|
| Schedule of Condensed Statements of Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended
December 31, |
|
2021 |
|
2020 |
|
2019 |
| Stock compensation expense |
$ |
39,523 |
|
|
$ |
25,200 |
|
|
$ |
18,225 |
|
| Equity in net loss (income) from subsidiaries |
100,426 |
|
|
253,571 |
|
|
(97,764) |
|
| Net (loss) income |
(139,949) |
|
|
(278,771) |
|
|
79,539 |
|
| Other comprehensive income (loss), net of tax: |
|
|
|
|
|
| Pension and postretirement benefits |
5,794 |
|
|
1,938 |
|
|
2,430 |
|
| Net gain (loss) from hedging activities |
2,914 |
|
|
166 |
|
|
(2,665) |
|
| Foreign currency translation |
10,611 |
|
|
(16,596) |
|
|
22,117 |
|
| Total other comprehensive income (loss) |
19,319 |
|
|
(14,492) |
|
|
21,882 |
|
| Comprehensive (loss) income |
$ |
(120,630) |
|
|
$ |
(293,263) |
|
|
$ |
101,421 |
|
|
|
|
|
|
|
|
| Schedule of Condensed Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
2021 |
|
December 31,
2020 |
| ASSETS |
|
|
|
|
|
|
|
| Investment in subsidiaries |
$ |
740,737 |
|
|
$ |
1,277,126 |
|
| Total assets |
$ |
740,737 |
|
|
$ |
1,277,126 |
|
| LIABILITIES |
|
|
|
|
|
|
|
| Total liabilities |
$ |
— |
|
|
$ |
— |
|
| STOCKHOLDERS' EQUITY |
|
|
|
Common stock (0.01 par); authorized shares 450,000,000; issued shares 137,820,971 and 137,102,143 on December 31, 2021 and 2020, respectively; outstanding shares 136,938,758 and 136,318,557 on December 31, 2021 and 2020, respectively |
1,378 |
|
|
1,371 |
|
Preferred stock (0.01 par); authorized shares 50,000,000; no shares issued or outstanding on December 31, 2021 and 2020, respectively |
— |
|
|
— |
|
| Additional paid-in capital |
1,073,409 |
|
|
1,477,859 |
|
| Accumulated deficit |
(315,707) |
|
|
(175,758) |
|
Treasury stock, at cost; shares 882,213 and 783,586 on December 31, 2021 and 2020, respectively |
(12,551) |
|
|
(11,081) |
|
| Accumulated other comprehensive loss |
(5,792) |
|
|
(15,265) |
|
| Total Ecovyst Inc. equity |
740,737 |
|
|
1,277,126 |
|
| Total liabilities and equity |
$ |
740,737 |
|
|
$ |
1,277,126 |
|
|
|
|
|
|
| Schedule of Condensed Statements of Cash Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended
December 31, |
|
2021 |
|
2020 |
|
2019 |
| Cash flows from operating activities: |
|
|
|
|
|
| Net (loss) income |
$ |
(139,949) |
|
|
$ |
(278,771) |
|
|
$ |
79,539 |
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
| Equity in net income from subsidiaries |
100,426 |
|
|
253,571 |
|
|
(97,764) |
|
| Stock compensation expense |
39,523 |
|
|
25,200 |
|
|
18,225 |
|
| Net cash provided by operating activities |
— |
|
|
— |
|
|
— |
|
| Cash flows from investing activities: |
|
|
|
|
|
| Distribution from subsidiaries |
435,593 |
|
|
243,749 |
|
|
— |
|
| Net cash provided by investing activities |
435,593 |
|
|
243,749 |
|
|
— |
|
| Cash flows from financing activities: |
|
|
|
|
|
| Dividends paid to stockholders |
(435,593) |
|
|
(243,749) |
|
|
— |
|
| Net cash used in financing activities |
(435,593) |
|
|
(243,749) |
|
|
— |
|
| Effect of exchange rate changes on cash, cash equivalents and restricted cash |
— |
|
|
— |
|
|
— |
|
| Net change in cash, cash equivalents and restricted cash |
— |
|
|
— |
|
|
— |
|
| Cash, cash equivalents and restricted cash at beginning of period |
— |
|
|
— |
|
|
— |
|
| Cash, cash equivalents and restricted cash at end of period of continuing operations |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|